About Exelixis, Inc.
Exelixis, Inc. is a genomics-based drug discovery company located in Alameda, California, and the producer of Cometriq, a treatment approved by the U.S. Food and Drug Administration for medullary thyroid cancer with clinical activity in several other types of metastatic cancer. The staff at Exelixis come from unusually diverse demographic backgrounds. The company is 45.2% female and 56.9% ethnic minorities. Despite its diversity in other areas, Exelixis employees are noticeably lacking in political diversity. It has an unusually high proportion of employees who are members of the Democratic Party, at 83.0%. Employees seem to enjoy working in an otherwise diverse workplace that is dominated by members of the Democratic Party.